Back

Sex-Dimorphic Associations of Prior Tuberculosis with Hypertension and Inflammatory Signature in People with HIV: a pilot study

Simweene, C. C.; Sibbenga, F.; Povia, J. P.; Masenga, S. K.

2026-01-15 hiv aids
10.64898/2026.01.12.26343987 medRxiv
Show abstract

BackgroundPeople with HIV (PWH) experience an increased burden of cardiovascular disease (CVD), partly driven by chronic immune activation despite antiretroviral therapy (ART). Tuberculosis (TB), a frequent co-infection, may leave persistent inflammatory sequelae even after cure, potentially accelerating hypertension and cardiovascular risk. Evidence on long-term cardiometabolic consequences of prior TB in virally suppressed PWH, particularly sex-specific effects, remains limited. MethodsIn a pilot cross-sectional study of 318 PWH, we compared demographics, cardiovascular parameters, and a panel of circulating inflammatory biomarkers between those with and without a history of TB. Logistic regression was used to identify factors associated with TB history in the whole cohort and stratified by sex. ResultsIn the 31 participants (9.7%) with prior TB, univariate analysis identified significant associations with older age, hypertension, longer ART duration, and elevated IL-6 and soluble ST2. Hypertension was strongly associated with TB history in females (OR 4.41, 95% CI: 3.41 (1.57, 7.41) p=0.003) but not males. In multivariate models adjusted for clinical variables, longer ART duration remained an independent correlate in the full cohort. Sex-stratified multivariate analysis revealed that lower IFN-{gamma} was associated with TB history in males (AOR 0.99, p=0.048), while lower IL-5 was associated with TB history in females (AOR 0.99, p=0.042). ConclusionA history of TB is associated with hypertension in PWH, particularly among females, and is linked to sex-specific differences in residual inflammatory pathways. These findings suggest that prior TB may contribute to cardiovascular risk in a sex-disparate manner, warranting further investigation.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
AIDS
31 papers in training set
Top 0.1%
18.8%
2
Brain, Behavior, and Immunity
105 papers in training set
Top 0.2%
10.2%
3
PLOS ONE
4510 papers in training set
Top 21%
8.5%
4
The Journal of Infectious Diseases
182 papers in training set
Top 0.3%
7.3%
5
Open Forum Infectious Diseases
134 papers in training set
Top 0.1%
6.4%
50% of probability mass above
6
BMC Infectious Diseases
118 papers in training set
Top 0.5%
4.9%
7
Clinical Infectious Diseases
231 papers in training set
Top 1%
4.4%
8
PLOS Medicine
98 papers in training set
Top 1%
3.6%
9
AIDS and Behavior
14 papers in training set
Top 0.2%
3.1%
10
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.8%
11
Vaccines
196 papers in training set
Top 1%
1.9%
12
eBioMedicine
130 papers in training set
Top 1%
1.7%
13
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.7%
14
Journal of the American Heart Association
119 papers in training set
Top 3%
1.5%
15
JAIDS Journal of Acquired Immune Deficiency Syndromes
19 papers in training set
Top 0.3%
1.3%
16
Cells
232 papers in training set
Top 3%
1.3%
17
Epigenetics
43 papers in training set
Top 0.7%
1.0%
18
Neuroscience
88 papers in training set
Top 2%
1.0%
19
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
20
PLOS Global Public Health
293 papers in training set
Top 5%
0.8%
21
Journal of The Royal Society Interface
189 papers in training set
Top 4%
0.8%
22
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.8%
23
Viruses
318 papers in training set
Top 5%
0.8%
24
BMJ Open
554 papers in training set
Top 13%
0.7%
25
Nature Medicine
117 papers in training set
Top 6%
0.5%
26
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.9%
0.5%
27
iScience
1063 papers in training set
Top 40%
0.5%